February 23, 2017
The National Cancer Center (NCC) said on February 22 that it will launch a PII investigator-initiated trial (IIT) on multi-drug remission-induction therapy for the treatment of acute lymphatic leukemia (ALL) in first-relapsed children. The program will be conducted at nine...read more